People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SentreHEART Inc | — | Biotechnology | Series B | $51.0M | $992.2M | 2012 |
Russell Sieber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Russell Sieber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Ferrari | 1 | 15 |
| Casey Tansey | 1 | 14 |
| Paul Buckman | 1 | 10 |
| Russell Hirsch | 1 | 10 |
| Steven Hochberg | 1 | 9 |
| Chen Yu | 1 | 7 |
| Victor Tong | 1 | 6 |
| Phil Young | 1 | 2 |
| William Cohn | 1 | 2 |
| Peter Osborne | 1 | 2 |
| Russell Seiber | 1 | 1 |
| Theodore Huber | 1 | 1 |
| Pam Simons | 1 | 1 |
| Greg Fung | 1 | 1 |
| Robert Strasser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.